EPPA
13.1.2023 05:01:38 CET | Business Wire | Press release
The European Paper Packaging Alliance (EPPA) has this week welcomed a new President and Director General.
At EPPA’s General Assembly on 9 January, Antonio D’Amato, CEO of Seda International Packaging Group and former president of Confindustria, the Confederation of Italian Industry, has been elected President. He took over from Eric Le Lay, President of Huhtamaki Fibre Food Service who is now Vice-President of the Alliance.
EPPA also appointed Matti Rantanen, an experienced packaging expert and public affairs professional, as its new Director General.
2023 will be a pivotal year for the European packaging industry as discussions on the EU’s proposed Packaging and Packaging Waste Regulation heat up. The European Commission is proposing the mass implementation of reusable packaging across a range of sectors - in spite of life cycle analysis clearly showing it to be the least sustainable choice. EPPA will be making the case for the best environmental, renewable and recyclable single-use paper packaging.
Incoming EPPA President Antonio D'Amato said:
"I am honoured to take on the Presidency of EPPA again and thank all its members, particularly Eric Le Lay, for their excellent work over the past year. EPPA increasingly represents the leading companies in Europe’s paper packaging supply chain, from forest, paper and board producers to converters and brand owners as well. We will maintain our focus on continuing the innovative, sustainable development of single-use paper packaging that is fully integrated in the circular economy.
Our mission is increasingly focused on supporting policymakers to make decisions based on solid scientific evidence. Single-use paper packaging has an essential role to play in reducing CO2 emissions while simultaneously reducing food waste, avoiding water stress and protecting consumer health."
Eric Le Lay, President of Fiber & Foodservice at Huhtamaki and Vice-President of EPPA said:
“I am delighted to pass on the torch to Antonio D’Amato this year. He brings a wealth of experience to the role. Our biggest challenge is to engage constructively on the complex Packaging and Packaging Waste Regulation file. We will continue to make the case for recyclable, renewable paper-based packaging at the heart of Europe’s circular economy and ensure that policies are based on science and evidence.”
Matti Rantanen, Director General of the European Paper Packaging Alliance added:
“I am excited to join EPPA and work to promote recyclable and renewable paper packaging as a solution to achieve a fully circular economy. Reviewing the EU’s packaging and packaging waste rules is crucial, yet it must be done rationally and in accordance with scientific evidence. EPPA’s studies have shown that in quick-service restaurants, both for in-store consumption and takeaway services, single-use paper packaging is simply better for the environment, the economy and consumer health. I am dedicated to getting this message across. As we continue to feel the effects of climate change and of the global economic crisis everyday, EPPA will continue to offer facts and evidence that should be acknowledged by policy makers.”
ENDS
About EPPA:
The European Paper Packaging Alliance is a non-for-profit food and foodservice packaging association. The priorities of the Alliance are to find concrete solutions to increase recycling and to reduce carbon emissions of food and foodservice packaging without compromising food safety and human health protection. More information is available here.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230112005686/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
